Menu

• Ask a Health Expert about NEUTROPHIL PERCENTAGE DECREASED
• Post Your Side Effect related to NEUTROPHIL PERCENTAGE DECREASED
• NEUTROPHIL PERCENTAGE DECREASED and FDA Warnings
• NEUTROPHIL PERCENTAGE DECREASED in Patients Wiki
• Report NEUTROPHIL PERCENTAGE DECREASED in Drug Side Effect Survey

NEUTROPHIL PERCENTAGE DECREASED side effect

What is NEUTROPHIL PERCENTAGE DECREASED ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Taxotere Side Effects Report #5715726-7
Consumer or non-health professional from UNITED STATES reported TAXOTERE problem on Apr 23, 2008. Male patient, weighting 241.4 lb, was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: neutrophil percentage decreased, white blood cell count decreased, . TAXOTERE dosage: 165 MG. During the same period patient was treated with COMBIVENT, LOMOTIL, LUPRON, PREDNISONE, PYRIDIUM, XANAX, ZOFRAN. Patient recovered.

Neoral Side Effects Report #5532734-X
NEORAL problem was reported by a Physician from JAPAN on Nov 26, 2007. Female patient, weighting 11.02 lb, was diagnosed with liver transplant, pyrexia, oedema, thrombosis prophylaxis, hypokalaemia and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: eosinophilia, neutrophil percentage decreased, platelet count decreased, white blood cell count increased, . NEORAL dosage: unknown. During the same period patient was treated with PROGRAF, SANDIMMUNE, PREDONINE, PREDNISOLONE ACETATE, SULPERAZON, LASIX, WARFARIN, KAYTWO. Patient was hospitalized. Patient recovered.

Neoral Side Effects Report #5567823-7
Physician from JAPAN reported NEORAL problem on Dec 14, 2007. Female patient, weighting 11.02 lb, was diagnosed with liver transplant, pyrexia, oedema, thrombosis prophylaxis, hypokalaemia and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: eosinophilia, neutrophil percentage decreased, platelet count decreased, white blood cell count increased, . NEORAL dosage: unknown. During the same period patient was treated with PROGRAF, SANDIMMUNE, PREDONINE, PREDNISOLONE ACETATE, SULPERAZON, LASIX, WARFARIN, KAYTWO. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5483069-5
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 27, 2007. Female patient, weighting 92.37 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: c-reactive protein increased, neutrophil percentage decreased, pyrexia, white blood cell count decreased, . BEVACIZUMAB dosage: 629 MG, Q3W. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, OXYCODONE, FENTANYL, METOCLOPRAMIDE, TRIAMCINOLONE, PROCHLORPERAZINE, LOXOPROFEN. Patient was hospitalized. Patient recovered.


Bisoprolol Side Effects Report #5652210-3
Consumer or non-health professional from JAPAN reported BISOPROLOL FUMARATE problem on Feb 29, 2008. Female patient, 81 years of age, was diagnosed with ventricular fibrillation and was treated with BISOPROLOL FUMARATE. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, aptyalism, neutrophil percentage decreased, oral candidiasis, pyrexia, white blood cell count decreased, . BISOPROLOL FUMARATE dosage: unknown. During the same period patient was treated with BISOPROLOL FUMARATE, ASPENON, WARFARIN, ARICEPT, FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Pravastatin Side Effects Report #5660423-X
PRAVASTATIN problem was reported by a Consumer or non-health professional from GREECE on Feb 25, 2008. Male patient, 60 years of age, was diagnosed with hypercholesterolaemia and was treated with PRAVASTATIN. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, lymphocyte percentage increased, neutrophil percentage decreased, pleural effusion, . PRAVASTATIN dosage: 40 MG; QD, 40 MG; QD. Patient recovered.

Tysabri Side Effects Report #5683489-X
Physician from UNITED STATES reported TYSABRI problem on Mar 12, 2008. Male patient, 54 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, mean cell haemoglobin concentration increased, neutrophil percentage decreased, platelet count decreased, white blood cell count increased, . TYSABRI dosage: 300 MG; QM; IV. Patient recovered.